Publication Name	World Journal of Diabetes
Manuscript ID	81855
Country	China

Received	2022-11-26 11:58
Peer-Review Started	2022-11-26 12:00
To Make the First Decision
Return for Revision	2022-12-12 20:59
Revised	2022-12-20 08:11
Second Decision	2023-01-18 03:19
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-01-19 19:25
Articles in Press	2023-01-19 19:25
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-01-26 06:40
Typeset the Manuscript	2023-02-08 03:46
Publish the Manuscript Online	2023-02-14 12:24

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Meta-Analysis
Article Title	Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Yun-Ran Guo, Xin-Ming Liu and Gui-Xia Wang
Funding Agency and Grant Number
Corresponding Author	Gui-Xia Wang, MD, PhD, Professor, Department of Endocrinology and Metabolism, The First Hospital of Jilin University, No. 71 Xinmin Street, Changchun 130000, Jilin Province, China. gwang168@jlu.edu.cn
Key Words	Proton pump inhibitors; Diabetes mellitus; Odds ratio; Meta-analysis
Core Tip	Exposure to proton pump inhibitors (PPIs) has been reported to have a potential role in the development of diabetes. No consistent results for the association between PPIs use and diabetes risk. This meta-analysis aimed to provide a more reliable assessment.
Publish Date	2023-02-14 12:24
Citation	Guo YR, Liu XM, Wang GX. Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis. World J Diabetes 2023; 14(2): 120-129
URL	https://www.wjgnet.com/1948-9358/full/v14/i2/120.htm
DOI	https://dx.doi.org/10.4239/wjd.v14.i2.120

Full Article (PDF)	WJD-14-120.pdf
Full Article (Word)	WJD-14-120.docx
Manuscript File	81855-Review-Filipodia.docx
Answering Reviewers	81855-Answering reviewers.pdf
Audio Core Tip	81855-Audio core tip.mp3
Biostatistics Review Certificate	81855-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	81855-Conflict-of-interest statement.pdf
Copyright License Agreement	81855-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	81855-Language certificate.pdf
Supplementary Material	81855-Supplementary material.pdf
Peer-review Report	81855-Peer-review(s).pdf
Scientific Misconduct Check	81855-Bing-Chen YL-2.png
Scientific Editor Work List	81855-Scientific editor work list.pdf
CrossCheck Report	81855-CrossCheck report.pdf